» Articles » PMID: 11558630

Mouse Models of Metastatic Pancreatic Adenocarcinoma

Overview
Specialty Gastroenterology
Date 2001 Sep 18
PMID 11558630
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic adenocarcinoma is a deadly disease. Its etiology is unknown, and metastatic disease kills the majority of patients who have it. Effective prevention is clearly the ultimate goal for eradicating this disease provided that the effects of environmental and genetic elements on pancreatic cancer development are fully understood. Currently, it appears that the control of pancreatic cancer metastasis is of immediate urgency. Fulfillment of this difficult task relies on knowledge of the cellular and molecular biology of metastasis. The use of relevant animal models will help define each aspect of this complicated process.

Citing Articles

Pathobiology of brain metastases.

Nathoo N, Chahlavi A, Barnett G, Toms S J Clin Pathol. 2005; 58(3):237-42.

PMID: 15735152 PMC: 1770599. DOI: 10.1136/jcp.2003.013623.

References
1.
Longnecker D . Carcinogenesis in the pancreas. Arch Pathol Lab Med. 1983; 107(2):54-8. View

2.
Xie K, Fidler I . Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev. 1998; 17(1):55-75. DOI: 10.1023/a:1005956721457. View

3.
Okita S, Tsutsumi M, Onji M, Konishi Y . p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters. Mol Carcinog. 1995; 13(4):266-71. DOI: 10.1002/mc.2940130409. View

4.
Folkman J . Tumor angiogenesis and tissue factor. Nat Med. 1996; 2(2):167-8. DOI: 10.1038/nm0296-167. View

5.
Boucher Y, Baxter L, Jain R . Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res. 1990; 50(15):4478-84. View